Highlights
The global Long Read Sequencing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Long Read Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Long Read Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Long Read Sequencing in Academic Research is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Long Read Sequencing include Oxford Nanopore Technologies, Pacific Biosciences of California, BaseClear B.V., Future Genomics Technologies, Garvan Institute of Medical Research, Genome Transcriptome Facility of Bordeaux, NextOmics, Takara Bio and Quantapore, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Long Read Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long Read Sequencing.
The Long Read Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Long Read Sequencing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long Read Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Oxford Nanopore Technologies
Pacific Biosciences of California
BaseClear B.V.
Future Genomics Technologies
Garvan Institute of Medical Research
Genome Transcriptome Facility of Bordeaux
NextOmics
Takara Bio
Quantapore
Stratos Genomics
MicrobesNG
Institute of Integrative Biology of the Cell
Segment by Type
Single-Molecule Real-Time Sequencing (SMRT)
Nanopore Sequencing
Segment by Application
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long Read Sequencing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Read Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Single-Molecule Real-Time Sequencing (SMRT)
1.2.3 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global Long Read Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Academic Research
1.3.3 Clinical Research
1.3.4 Hospitals & Clinics
1.3.5 Pharma & Biotech Entities
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long Read Sequencing Market Perspective (2018-2029)
2.2 Long Read Sequencing Growth Trends by Region
2.2.1 Global Long Read Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Long Read Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Long Read Sequencing Forecasted Market Size by Region (2024-2029)
2.3 Long Read Sequencing Market Dynamics
2.3.1 Long Read Sequencing Industry Trends
2.3.2 Long Read Sequencing Market Drivers
2.3.3 Long Read Sequencing Market Challenges
2.3.4 Long Read Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Read Sequencing Players by Revenue
3.1.1 Global Top Long Read Sequencing Players by Revenue (2018-2023)
3.1.2 Global Long Read Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Long Read Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Read Sequencing Revenue
3.4 Global Long Read Sequencing Market Concentration Ratio
3.4.1 Global Long Read Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Read Sequencing Revenue in 2022
3.5 Long Read Sequencing Key Players Head office and Area Served
3.6 Key Players Long Read Sequencing Product Solution and Service
3.7 Date of Enter into Long Read Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Read Sequencing Breakdown Data by Type
4.1 Global Long Read Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Long Read Sequencing Forecasted Market Size by Type (2024-2029)
5 Long Read Sequencing Breakdown Data by Application
5.1 Global Long Read Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Long Read Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Long Read Sequencing Market Size (2018-2029)
6.2 North America Long Read Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Long Read Sequencing Market Size by Country (2018-2023)
6.4 North America Long Read Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long Read Sequencing Market Size (2018-2029)
7.2 Europe Long Read Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Long Read Sequencing Market Size by Country (2018-2023)
7.4 Europe Long Read Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Read Sequencing Market Size (2018-2029)
8.2 Asia-Pacific Long Read Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Long Read Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Long Read Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long Read Sequencing Market Size (2018-2029)
9.2 Latin America Long Read Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Long Read Sequencing Market Size by Country (2018-2023)
9.4 Latin America Long Read Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Read Sequencing Market Size (2018-2029)
10.2 Middle East & Africa Long Read Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Long Read Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Long Read Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Oxford Nanopore Technologies
11.1.1 Oxford Nanopore Technologies Company Detail
11.1.2 Oxford Nanopore Technologies Business Overview
11.1.3 Oxford Nanopore Technologies Long Read Sequencing Introduction
11.1.4 Oxford Nanopore Technologies Revenue in Long Read Sequencing Business (2018-2023)
11.1.5 Oxford Nanopore Technologies Recent Development
11.2 Pacific Biosciences of California
11.2.1 Pacific Biosciences of California Company Detail
11.2.2 Pacific Biosciences of California Business Overview
11.2.3 Pacific Biosciences of California Long Read Sequencing Introduction
11.2.4 Pacific Biosciences of California Revenue in Long Read Sequencing Business (2018-2023)
11.2.5 Pacific Biosciences of California Recent Development
11.3 BaseClear B.V.
11.3.1 BaseClear B.V. Company Detail
11.3.2 BaseClear B.V. Business Overview
11.3.3 BaseClear B.V. Long Read Sequencing Introduction
11.3.4 BaseClear B.V. Revenue in Long Read Sequencing Business (2018-2023)
11.3.5 BaseClear B.V. Recent Development
11.4 Future Genomics Technologies
11.4.1 Future Genomics Technologies Company Detail
11.4.2 Future Genomics Technologies Business Overview
11.4.3 Future Genomics Technologies Long Read Sequencing Introduction
11.4.4 Future Genomics Technologies Revenue in Long Read Sequencing Business (2018-2023)
11.4.5 Future Genomics Technologies Recent Development
11.5 Garvan Institute of Medical Research
11.5.1 Garvan Institute of Medical Research Company Detail
11.5.2 Garvan Institute of Medical Research Business Overview
11.5.3 Garvan Institute of Medical Research Long Read Sequencing Introduction
11.5.4 Garvan Institute of Medical Research Revenue in Long Read Sequencing Business (2018-2023)
11.5.5 Garvan Institute of Medical Research Recent Development
11.6 Genome Transcriptome Facility of Bordeaux
11.6.1 Genome Transcriptome Facility of Bordeaux Company Detail
11.6.2 Genome Transcriptome Facility of Bordeaux Business Overview
11.6.3 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Introduction
11.6.4 Genome Transcriptome Facility of Bordeaux Revenue in Long Read Sequencing Business (2018-2023)
11.6.5 Genome Transcriptome Facility of Bordeaux Recent Development
11.7 NextOmics
11.7.1 NextOmics Company Detail
11.7.2 NextOmics Business Overview
11.7.3 NextOmics Long Read Sequencing Introduction
11.7.4 NextOmics Revenue in Long Read Sequencing Business (2018-2023)
11.7.5 NextOmics Recent Development
11.8 Takara Bio
11.8.1 Takara Bio Company Detail
11.8.2 Takara Bio Business Overview
11.8.3 Takara Bio Long Read Sequencing Introduction
11.8.4 Takara Bio Revenue in Long Read Sequencing Business (2018-2023)
11.8.5 Takara Bio Recent Development
11.9 Quantapore
11.9.1 Quantapore Company Detail
11.9.2 Quantapore Business Overview
11.9.3 Quantapore Long Read Sequencing Introduction
11.9.4 Quantapore Revenue in Long Read Sequencing Business (2018-2023)
11.9.5 Quantapore Recent Development
11.10 Stratos Genomics
11.10.1 Stratos Genomics Company Detail
11.10.2 Stratos Genomics Business Overview
11.10.3 Stratos Genomics Long Read Sequencing Introduction
11.10.4 Stratos Genomics Revenue in Long Read Sequencing Business (2018-2023)
11.10.5 Stratos Genomics Recent Development
11.11 MicrobesNG
11.11.1 MicrobesNG Company Detail
11.11.2 MicrobesNG Business Overview
11.11.3 MicrobesNG Long Read Sequencing Introduction
11.11.4 MicrobesNG Revenue in Long Read Sequencing Business (2018-2023)
11.11.5 MicrobesNG Recent Development
11.12 Institute of Integrative Biology of the Cell
11.12.1 Institute of Integrative Biology of the Cell Company Detail
11.12.2 Institute of Integrative Biology of the Cell Business Overview
11.12.3 Institute of Integrative Biology of the Cell Long Read Sequencing Introduction
11.12.4 Institute of Integrative Biology of the Cell Revenue in Long Read Sequencing Business (2018-2023)
11.12.5 Institute of Integrative Biology of the Cell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Oxford Nanopore Technologies
Pacific Biosciences of California
BaseClear B.V.
Future Genomics Technologies
Garvan Institute of Medical Research
Genome Transcriptome Facility of Bordeaux
NextOmics
Takara Bio
Quantapore
Stratos Genomics
MicrobesNG
Institute of Integrative Biology of the Cell
听
听
*If Applicable.
